Fahad Alsaikhan

2.1k citations
103 papers · 1.5k indexed · h-index 23
Topics
MicroRNA in disease regulation (18 papers)Circular RNAs in diseases (15 papers)Cancer-related molecular mechanisms research (11 papers)
Partner nations
Saudi ArabiaIraqIran

In The Last Decade

Fahad Alsaikhan

100 papers receiving 1.4k citations

Peers

Fahad Alsaikhan
Comparison fields: 5 of 155
  • Molecular Biology 387
  • Biomedical Engineering 262
  • Biomaterials 204
  • Oncology 185
  • Materials Chemistry 179
Replace Shujing Li with:
Shujing Li China
Yuxuan Zhu China
Yaru Zhang China
Aimei Li China
Tingting Cao China
V. Sivaramakrishnan India
Dandan Zheng China
Dawei Gao China
Daisuke Sasaki Japan
Fahad Alsaikhan relative to Shujing Li China Shujing Li's profile →
Citations per field
00.5×2.6×
Shujing Li · 1×
Citations per year

Countries citing papers authored by Fahad Alsaikhan

Since Specialization
Citations

This map shows the geographic impact of Fahad Alsaikhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fahad Alsaikhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fahad Alsaikhan more than expected).

Fields of papers citing papers by Fahad Alsaikhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fahad Alsaikhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fahad Alsaikhan. The network helps show where Fahad Alsaikhan may publish in the future.

Co-authorship network of co-authors of Fahad Alsaikhan

This figure shows the co-authorship network connecting the top 25 collaborators of Fahad Alsaikhan. A scholar is included among the top collaborators of Fahad Alsaikhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fahad Alsaikhan. Fahad Alsaikhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 39
3 29
4 5
5 17
6 18
7 0
8 7
9 9
10 9
11 8
12 48
13 2
14 10
15 11
16 8
17 104
18 8
19 5
20
Intralesional OK-432 (Picibanil) Sclerosing Agent in the Treatment of Orbital Lymphangiomas
2

About Fahad Alsaikhan

Fahad Alsaikhan is a scholar working on Cancer Research, General Dentistry and Biomaterials, having authored 103 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (11 papers). The work is most often cited by research in Biomaterials (204 citations), Molecular Medicine (64 citations) and Pharmaceutical Science (56 citations). Fahad Alsaikhan has collaborated with scholars based in Saudi Arabia, Iraq and Iran. Frequent co-authors include Abduladheem Turki Jalil, Bagher Farhood, Andrés Alexis Ramírez‐Coronel, Moaed E. Al‐Gazally, Pushpamala Ramaiah, Maria Jade Catalan Opulencia, Jitendra Gupta, Mustafa M. Kadhim, Jahidur Rashid and Fakhrul Ahsan. Their work appears in journals such as PLoS ONE, Molecules and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026